View of Pathogenic TP53 mutations influence chemotherapy response and survival rate of patients with HPV-negative oral carcinomas

Return to Article Details Pathogenic TP53 mutations influence chemotherapy response and survival rate of patients with HPV-negative oral carcinomas Download Download PDF